Osteomyelitis

Disease-a-Month

Volumn 56, Issue 1, 2010, Pages 6-31

  Chihara, Shingo ^a   Segreti, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; FLUORODEOXYGLUCOSE F 18; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MEROPENEM; MONOCLONAL ANTIBODY; NAFCILLIN; OXACILLIN; OXYGEN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIFAMPICIN; SULTAMICILLIN; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE; WARFARIN; ANTIINFECTIVE AGENT;

ADD ON THERAPY; ANTIBIOTIC THERAPY; BLOOD CULTURE; BONE BIOPSY; BONE INFECTION; BONE MARROW TOXICITY; BONE RADIOGRAPHY; BONE SCINTISCANNING; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; INCIDENCE; INFECTION RISK; INFLAMMATION; LABORATORY TEST; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; TISSUE CULTURE; DEBRIDEMENT;

ANTI-BACTERIAL AGENTS; DEBRIDEMENT; DIAGNOSTIC IMAGING; HUMANS; OSTEOMYELITIS;

EID: 71049162568     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2009.07.001     Document Type: Review

References (103)

1. Browner B.D. Skeletal trauma basic science, management, and reconstruction. In: Browner B.D. (Ed). MDConsult. (ed 4) (2009), Saunders/Elsevier, Philadelphia, PA
2. Waldvogel F.A., Medoff G., and Swartz M.N. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 282 (1970) 198-206
3. Browner B.D. Skeletal trauma basic science, management, and reconstruction. (ed 3) (2003), W. B. Saunders, Philadelphia, PA
4. Gillespie W.J. Epidemiology in bone and joint infection. Infect Dis Clin North Am 4 (1990) 361-376
5. Harrison's principles of internal medicine (2008), McGraw-Hill Medical. http://www.accessmedicine.com/resourcetoc.aspx?resourceID=4
6. Singh N., Armstrong D.G., and Lipsky B.A. Preventing foot ulcers in patients with diabetes. J Am Med Assoc 293 (2005) 217-228
7. Lipsky B.A., Pecoraro R.E., and Wheat L.J. The diabetic foot. Soft tissue and bone infection. Infect Dis Clin North Am 4 (1990) 409-432
8. Berendt A.R., Peters E.J., Bakker K., et al. Diabetic foot osteomyelitis: A progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 24 suppl 1 (2008) S145-S161
9. Bamberger D.M., Daus G.P., and Gerding D.N. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 83 (1987) 653-660
10. Nather A., Bee C.S., Huak C.Y., et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications 22 (2008) 77-82
11. Foster T.J., and Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 6 (1998) 484-488
12. Patti J.M., Bremell T., Krajewska-Pietrasik D., et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 62 (1994) 152-161
13. Greenberg D.P., Bayer A.S., Cheung A.L., et al. Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model. Infect Immun 57 (1989) 1113-1118
14. Littlewood-Evans A.J., Hattenberger M.R., Luscher C., et al. Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun 65 (1997) 3438-3443
15. Ziran B.H. Osteomyelitis. J Trauma 62 (2007) S59-S60
16. Ciampolini J., and Harding K.G. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?. Postgrad Med J 76 (2000) 479-483
17. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (2005), Elsevier/Churchill Livingstone. http://atoz.ebsco.com/link.asp?id=7227&sid=128189840&rid=400072&urlSource=AtoZ&lang=en
18. Waldvogel F.A., Medoff G., and Swartz M.N. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects (second of three parts). N Engl J Med 282 (1970) 260-266
19. Waldvogel F.A., Medoff G., and Swartz M.N. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med 282 (1970) 316-322
20. Cierny III G., Mader J.T., and Penninck J.J. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res (2003) 7-24
21. Lew D.P., and Waldvogel F.A. Osteomyelitis. N Engl J Med 336 (1997) 999-1007
22. Sabir N., Rafi S., Hashmi I., et al. Lumbar osteomyelitis with Pseudomonas. J Pak Med Assoc 57 (2007) 517-518
23. Maman E., Bickels J., Ephros M., et al. Musculoskeletal manifestations of cat scratch disease. Clin Infect Dis 45 (2007) 1535-1540
24. Stratov I., Korman T.M., and Johnson P.D. Management of aspergillus osteomyelitis: Report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 22 (2003) 277-283
25. Petitjean G., Fluckiger U., Scharen S., et al. Vertebral osteomyelitis caused by non-tuberculous mycobacteria. Clin Microbiol Infect 10 (2004) 951-953
26. Haller P., Bruderer T., Schaeren S., et al. Vertebral osteomyelitis caused by Actinobaculum schaalii: A difficult-to-diagnose and potentially invasive uropathogen. Eur J Clin Microbiol Infect Dis 26 (2007) 667-670
27. Mouzopoulos G., Stamatakos M., Tzurbakis M., et al. Lower extremity infections by Vibrio vulnificus. Chirurgia 103 (2008) 201-203
28. Vasoo S., Yeo S.B., Lim P.L., et al. Efficacy of voriconazole for Scedosporium apiospermum skull base osteomyelitis: Case report and literature review. Int J Antimicrob Agents 31 (2008) 184-185
29. Amit A., Sudish K., and Pople I.K. Primary calvarial cryptococcal osteomyelitis in a patient with idiopathic lymphopenia. Acta Neurochir 150 (2008) 713-714
30. Oppenheimer M., Embil J.M., Black B., et al. Blastomycosis of bones and joints. South Med J 100 (2007) 570-578
31. Yun H.C., Branstetter J.G., and Murray C.K. Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J Trauma 64 (2008) S163-S168
32. Phanzu D.M., Bafende E.A., Dunda B.K., et al. Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg 75 (2006) 311-314
33. Livesley N.J., and Chow A.W. Infected pressure ulcers in elderly individuals. Clin Infect Dis 35 (2002) 1390-1396
34. Allman R.M. Pressure ulcer prevalence, incidence, risk factors, and impact. Clin Geriatr Med 13 (1997) 421-436
35. Garibaldi R.A., Brodine S., and Matsumiya S. Infections among patients in nursing homes: Policies, prevalence, problems. N Engl J Med 305 (1981) 731-735
36. Darouiche R.O., Landon G.C., Klima M., et al. Osteomyelitis associated with pressure sores. Arch Intern Med 154 (1994) 753-758
37. Huang A.B., Schweitzer M.E., Hume E., et al. Osteomyelitis of the pelvis/hips in paralyzed patients: Accuracy and clinical utility of MRI. J Comput Assist Tomogr 22 (1998) 437-443
38. Thomas D.R. The role of nutrition in prevention and healing of pressure ulcers. Clin Geriatr Med 13 (1997) 497-511
39. Grammatico L., Baron S., Rusch E., et al. Epidemiology of vertebral osteomyelitis (VO) in France: Analysis of hospital-discharge data 2002-2003. Epidemiol Infect 136 (2008) 653-660
40. Sapico F.L., and Montgomerie J.Z. Pyogenic vertebral osteomyelitis: Report of nine cases and review of the literature. Rev Infect Dis 1 (1979) 754-776
41. Nolla J.M., Ariza J., Gomez-Vaquero C., et al. Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum 31 (2002) 271-278
42. Torda A.J., Gottlieb T., and Bradbury R. Pyogenic vertebral osteomyelitis: Analysis of 20 cases and review. Clin Infect Dis 20 (1995) 320-328
43. Kak V., and Chandrasekar P.H. Bone and joint infections in injection drug users. Infect Dis Clin North Am 16 (2002) 681-695
44. Pigrau C., Almirante B., Flores X., et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: Incidence, risk factors, and outcome. Am J Med 118 (2005) 1287
45. Falagas M.E., Bliziotis I.A., Mavrogenis A.F., et al. Spondylodiscitis after facet joint steroid injection: A case report and review of the literature. Scand J Infect Dis 38 (2006) 295-299
46. Cunha B.A. Osteomyelitis in elderly patients. Clin Infect Dis 35 (2002) 287-293
47. Lew D.P., and Waldvogel F.A. Osteomyelitis. Lancet 364 (2004) 369-379
48. Bass S.N., Ailani R.K., Shekar R., et al. Pyogenic vertebral osteomyelitis presenting as exudative pleural effusion: A series of five cases. Chest 114 (1998) 642-647
49. Abe E., Yan K., and Okada K. Pyogenic vertebral osteomyelitis presenting as single spinal compression fracture: A case report and review of the literature. Spinal Cord 38 (2000) 639-644
50. Levin M.H., Weinstein R.A., Nathan C., et al. Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine. J Clin Microbiol 20 (1984) 758-762
51. Swisher L.A., Roberts J.R., and Glynn M.J. Needle licker's osteomyelitis. Am J Emerg Med 12 (1994) 343-346
52. Suedkamp N.P., Barbey N., Veuskens A., et al. The incidence of osteitis in open fractures: An analysis of 948 open fractures (a review of the Hannover experience). J Orthop Trauma 7 (1993) 473-482
53. Kindsfater K., and Jonassen E.A. Osteomyelitis in grade II and III open tibia fractures with late debridement. J Orthop Trauma 9 (1995) 121-127
54. Zalavras C.G., Gupta N., Patzakis M.J., et al. Microbiology of osteomyelitis in patients infected with the human immunodeficiency virus. Clin Orthop Relat Res 439 (2005) 97-100
55. Weinstein M.A., and Eismont F.J. Infections of the spine in patients with human immunodeficiency virus. J Bone Joint Surg Am 87 (2005) 604-609
56. Feng P.H., and Tan T.H. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 41 (1982) 11-14
57. Klein M.B., and Chang J. Management of hand and upper-extremity infections in heart transplant recipients. Plast Reconstr Surg 106 (2000) 598-601
58. Cunha B.A. Fever of unknown origin: Focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin North Am 21 (2007) 1137-1187
59. Butalia S., Palda V.A., Sargeant R.J., et al. Does this patient with diabetes have osteomyelitis of the lower extremity?. J Am Med Assoc 299 (2008) 806-813
60. Lipsky B.A. Bone of contention: Diagnosing diabetic foot osteomyelitis. Clin Infect Dis 47 (2008) 528-530
61. Walenkamp G.H. Chronic osteomyelitis. Acta Orthop Scand 68 (1997) 497-506
62. Newman L.G., Waller J., Palestro C.J., et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. J Am Med Assoc 266 (1991) 1246-1251
63. Senneville E., Melliez H., Beltrand E., et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: Concordance with ulcer swab cultures. Clin Infect Dis 42 (2006) 57-62
64. Grayson M.L., Gibbons G.W., Balogh K., et al. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. J Am Med Assoc 273 (1995) 721-723
65. Mackowiak P.A., Jones S.R., and Smith J.W. Diagnostic value of sinus-tract cultures in chronic osteomyelitis. J Am Med Assoc 239 (1978) 2772-2775
66. Zuluaga A.F., Galvis W., Jaimes F., et al. Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: An observational study. BMC Infect Dis 2 (2002) 8
67. Altay M., Arikan M., Yildiz Y., et al. Squamous cell carcinoma arising in chronic osteomyelitis in foot and ankle. Foot Ankle Int 25 (2004) 805-809
68. Ziets R.J., Evanski P.M., Lusskin R., et al. Squamous cell carcinoma complicating chronic osteomyelitis in a toe: A case report and review of the literature. Foot Ankle 12 (1991) 178-181
69. Wu J.S., Gorbachova T., Morrison W.B., et al. Imaging-guided bone biopsy for osteomyelitis: Are there factors associated with positive or negative cultures?. AJR Am J Roentgenol 188 (2007) 1529-1534
70. Trampuz A., Piper K.E., Jacobson M.J., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357 (2007) 654-663
71. Dinh M.T., Abad C.L., and Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: Meta-analysis. Clin Infect Dis 47 (2008) 519-527
72. Schauwecker D.S. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol 158 (1992) 9-18
73. Gold R.H., Hawkins R.A., and Katz R.D. Bacterial osteomyelitis: Findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol 157 (1991) 365-370
74. Pineda C., Vargas A., and Rodriguez A.V. Imaging of osteomyelitis: Current concepts. Infect Dis Clin North Am 20 (2006) 789-825
75. Termaat M.F., Raijmakers P.G., Scholten H.J., et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: A systematic review and meta-analysis. J Bone Joint Surg Am 87 (2005) 2464-2471
76. Ram P.C., Martinez S., Korobkin M., et al. CT detection of intraosseous gas: A new sign of osteomyelitis. AJR Am J Roentgenol 137 (1981) 721-723
77. Guhlmann A., Brecht-Krauss D., Suger G., et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 39 (1998) 2145-2152
78. Zhuang H., Duarte P.S., Pourdehand M., et al. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 25 (2000) 281-284
79. Kalicke T., Schmitz A., Risse J.H., et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: Results of histologically confirmed cases. Eur J Nucl Med 27 (2000) 524-528
80. Keidar Z., Militianu D., Melamed E., et al. The diabetic foot: Initial experience with 18F-FDG PET/CT. J Nucl Med 46 (2005) 444-449
81. Love C., Tomas M.B., Tronco G.G., et al. FDG PET of infection and inflammation. Radiographics 25 (2005) 1357-1368
82. Senneville E., Lombart A., Beltrand E., et al. Outcome of diabetic foot osteomyelitis treated nonsurgically: A retrospective cohort study. Diabetes Care 31 (2008) 637-642
83. Lipsky B.A. Medical treatment of diabetic foot infections. Clin Infect Dis 39 suppl 2 (2004) S104-S114
84. Priest D.H., and Peacock Jr. J.E. Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: Clinical features and therapeutic outcomes. South Med J 98 (2005) 854-862
85. Walsh T.J., Anaissie E.J., Denning D.W., et al. Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 (2008) 327-360
86. Pappas P.G., Rex J.H., Sobel J.D., et al. Guidelines for treatment of candidiasis. Clin Infect Dis 38 (2004) 161-189
87. American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 52 (2003) 1-77
88. Rao N., and Lipsky B.A. Optimising antimicrobial therapy in diabetic foot infections. Drugs 67 (2007) 195-214
89. Blaser J., Vergeres P., Widmer A.F., et al. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 39 (1995) 1134-1139
90. Zimmerli W., Widmer A.F., Blatter M., et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Foreign-Body Infection (FBI) Study Group. J Am Med Assoc 279 (1998) 1537-1541
91. Perlroth J., Kuo M., Tan J., et al. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: A systematic review of the literature. Arch Intern Med 168 (2008) 805-819
92. Peralta F.G., Sanchez M.B., Roiz M.P., et al. Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam. Clin Infect Dis 37 (2003) 1568-1572
93. Vercillo M., Patzakis M.J., Holtom P., et al. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res 461 (2007) 40-43
94. Patel R., Piper K.E., Rouse M.S., et al. Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob Agents Chemother 44 (2000) 3438-3440
95. Lamp K.C., Friedrich L.V., Mendez-Vigo L., et al. Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med 120 (2007) S13-S20
96. Henke P.K., Blackburn S.A., Wainess R.W., et al. Osteomyelitis of the foot and toe in adults is a surgical disease: Conservative management worsens lower extremity salvage. Ann Surg 241 (2005) 885-892 discussion 92-4
97. Peck K.R., Son D.W., Song J.H., et al. Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro. J Korean Med Sci 16 (2001) 39-44
98. de Lalla F., Pellizzer G., Strazzabosco M., et al. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 45 (2001) 1094-1098
99. Patti J.M. A humanized monoclonal antibody targeting Staphylococcus aureus. Vaccine 22 suppl 1 (2004) S39-S43
100. Tice A.D., Hoaglund P.A., and Shoultz D.A. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med 114 (2003) 723-728
101. Apelqvist J., Larsson J., and Agardh C.D. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 233 (1993) 485-491
102. Tice A.D., Hoaglund P.A., and Shoultz D.A. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 51 (2003) 1261-1268
103. Dombrowski J.C., and Winston L.G. Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections. J Infect 57 (2008) 110-115